Thermo Fisher Scientific Strengthens Bioproduction Offering by Acquiring Advanced Scientifics, Inc.

Download IconDownload Print IconPrint

Thermo Fisher Scientific Strengthens Bioproduction Offering by Acquiring Advanced Scientifics, Inc.

Client News

Related Solutions

WilmerHale lawyers have decades of experience advising public and private companies in all aspects of mergers and acquisitions.
Advising life sciences innovators, investors and industry leaders on complex transactions, legal issues and business challenges.
WilmerHale’s corporate lawyers have a long history of experience with cross-border deals involving mergers and acquisitions, public offerings and capital markets, venture capital, joint ventures and other transactions.

Thermo Fisher Scientific Inc., the world leader in serving science, today announced it has acquired Advanced Scientifics, Inc. (ASI), a global provider of single-use technologies for customized bioprocessing solutions, for $300 million in cash.

ASI designs, manufactures and delivers customized single-use systems and equipment for the preparation, processing, storage and transportation of biopharmaceuticals. The company has 380 employees and operations in Pennsylvania and Mexico.

WilmerHale is representing Thermo Fisher Scientific in this transaction, with a team led by Partner Hal Leibowitz that included Partners Joseph Conahan, Dr. Jan Heithecker, Paul Jakubowski, Belinda Juran, Amy Null, Julie Hogan Rodgers, Laura Schneider;  Counsel Ciara Baker; and Associates Iza Ryland and Julie Fogarty.

Thermo Fisher Scientific's press release can be found on their site. 

Notice

Unless you are an existing client, before communicating with WilmerHale by e-mail (or otherwise), please read the Disclaimer referenced by this link.(The Disclaimer is also accessible from the opening of this website). As noted therein, until you have received from us a written statement that we represent you in a particular manner (an "engagement letter") you should not send to us any confidential information about any such matter. After we have undertaken representation of you concerning a matter, you will be our client, and we may thereafter exchange confidential information freely.

Thank you for your interest in WilmerHale.

I Accept Cancel